Allergy Shots for Dust: Dust Is Not an Allergen — Dust Mite Usually Is
"Dust allergy" almost always means house dust mite allergy — SCIT targets the specific allergens within house dust, not dust as a category. House dust is a composite of dust mite (Der p/Der f), pet dander (Fel d 1, Can f 1), indoor mold, cockroach allergen (Bla g 1/2), and fiber particles. FDA-standardized SCIT extracts and the Odactra SLIT tablet (FDA-approved ages 5–65) target Der p/Der f specifically. Component testing before treatment identifies the actual driver.
6 peer-reviewed sources
Allergy shots for dust target dust mite (Der p/Der f), not 'dust' as a category. Dust is a composite allergen — component IgE testing (Der p 1, Fel d 1, Bla g 1) identifies the true driver before SCIT is formulated. Odactra SLIT tablet is FDA-approved for house dust mite.
The essentials
"Allergy shots for dust" must begin with an essential disambiguation: dust itself is not an allergen. House dust is a composite of multiple IgE-triggering components, and SCIT targets specific proteins within that composite — not dust as a category. Identifying which component of dust is actually driving symptoms before formulating an immunotherapy extract is the most important step that distinguishes effective treatment from expensive guesswork.
Curex's at-home IgE testing distinguishes the actual triggers within the house-dust composite — dust mite (Der p, Der f), pet dander (Fel d 1, Can f 1), indoor mold, cockroach — so the immunotherapy plan targets the real driver rather than "dust" as a category.
The dust composite breaks down as follows:
(1) House dust mite — the dominant driver in most cases. Dermatophagoides pteronyssinus (Der p) and Dermatophagoides farinae (Der f) are arthropods approximately 0.3mm long that feed on shed human skin, thrive at 25°C and 70–80% relative humidity, and produce the major allergens Der p 1 and Der p 2 (cysteine protease and NPC2-family lipid-binding proteins respectively). Der p 1 / Der f 1 cross-react; Der p 2 / Der f 2 cross-react. FDA-standardized extracts for Der p and Der f are available (CBER allergenic extracts list). The strongest modern HDM immunotherapy evidence is for the SLIT tablet Odactra (house dust mite, Merck) — FDA-approved originally for ages 18–65, expanded to 12–65, and further expanded to ages 5–65 in the 2025 label revision. Mosbech 2014 JACI (n=604, ALK SQ-HDM tablet) documented significant steroid-sparing benefit in asthma patients.
(2) Animal dander cross-contamination. Fel d 1 (cat major allergen) is detected in 99.9% of US homes including cat-free homes at approximately 1.0 µg/g geometric mean (Salo et al., NHANES analysis). Cat dander is airborne, sticky, and transfers via clothing — explaining why "dust-allergic" patients who have never owned a cat may have Fel d 1-positive IgE. SCIT for cat allergy requires FDA-standardized cat-hair extract (Greer license #308, 10,000 BAU/mL).
(3) Cockroach allergen — major inner-city asthma trigger. Blattella germanica (German cockroach) produces Bla g 1 and Bla g 2, found in over 90% of inner-city homes. Mouse urine allergen Mus m 1 is the other primary paired urban indoor allergen from NIEHS-funded inner-city asthma research. SCIT for cockroach is practiced but evidence base is limited — the CRITICAL trial (2024) failed its primary endpoint for cockroach SCIT.
(4) Indoor mold. Alternaria spores penetrate indoor environments seasonally. SCIT for Alternaria has two confirming DBPC RCTs (Kuna 2011 JACI; Tabar 2019 JACI). Other indoor molds lack comparable evidence.
(5) Fibers and food particles — mechanical irritants and food proteins, not IgE allergens. Not SCIT-treatable.
Component-resolved testing for Der p 1, Der p 2, Fel d 1, Can f 1, and Bla g 1 clarifies which component of the dust composite is the actual IgE driver before extract selection.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Efficacy by allergen — what the data shows
Dust mite (Der p/Der f) SCIT has a well-documented evidence base, including both injected and sublingual formulations. The Odactra SLIT tablet provides the strongest modern RCT anchoring for HDM-specific immunotherapy.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
What exactly causes 'dust allergy'?
True 'dust allergy' is almost always allergy to house dust mite (HDM) — specifically Dermatophagoides pteronyssinus (Der p) and Dermatophagoides farinae (Der f). These are microscopic arthropods that live in household dust, feed on shed human skin cells, and produce the major allergens Der p 1 (a cysteine protease) and Der p 2 (an NPC2-family lipid-binding protein). HDM thrive in warm, humid conditions — bedding, upholstered furniture, and carpets are the primary reservoirs. Less commonly, 'dust allergy' symptoms may be driven by cat dander (Fel d 1 contaminates 99.9% of US homes), cockroach allergen (Bla g 1, Bla g 2), indoor mold (Alternaria), or mouse urine (Mus m 1). Component IgE testing identifies which protein is the actual driver.
Is there a dust mite allergy shot?
Yes — FDA-standardized Der p and Der f SCIT extracts are available for injection-based immunotherapy. The strongest modern evidence is for the FDA-approved house dust mite SLIT tablet Odactra (Merck), which targets both Der p and Der f. Odactra was originally approved for ages 18–65, expanded to 12–65, and further expanded to 5–65 in the 2025 label revision. Mosbech 2014 JACI (n=604 asthma patients, SQ-HDM tablet, ALK) documented significant inhaled corticosteroid-sparing benefit while maintaining asthma control. Traditional injection SCIT using standardized Der p/Der f extract is also available and practiced clinically.
Can allergy shots help if I'm allergic to both dust mite and cat?
Yes — a multi-allergen SCIT vial can include both Der p/Der f (dust mite) and FDA-standardized cat-hair extract (Greer license #308, 10,000 BAU/mL) simultaneously, along with any other confirmed sensitizations. The extract is customized based on IgE testing results. Cat SCIT has documented efficacy: Alvarez-Cuesta 1994 JACI, Varney 1997 Clin Exp Allergy, and Lent 2006 JACI collectively establish cat SCIT as the most RCT-supported pet dander immunotherapy, with approximately 70–72% symptom reduction in controlled challenge studies. Both dust mite and cat extracts are FDA-standardized, making them among the highest-potency-characterized extracts available.
Should I get tested for dust mite allergy before starting shots?
Yes — IgE component testing for Der p 1 and Der p 2 should precede dust mite SCIT initiation. Dust mite sensitization is confirmed by a positive skin prick test (wheal ≥3mm above negative control) or serum-specific IgE (≥0.35 kUA/L). Component-resolved testing additionally distinguishes primary Der p 1/p 2 sensitization from cross-reactive responses and identifies whether cat dander (Fel d 1), cockroach (Bla g 1, Bla g 2), or other dust-composite components require inclusion in the extract. A patient receiving dust mite SCIT that doesn't include the actual primary sensitizer will not benefit — the diagnostic step is not optional.
What is Odactra and how does it compare to allergy shots for dust?
Odactra (house dust mite sublingual allergen immunotherapy tablet, Merck) is the FDA-approved SLIT tablet for house dust mite allergy in patients aged 5–65 (as of the 2025 label expansion). It is taken daily as a sublingual tablet dissolved under the tongue at home after one supervised first-dose clinic visit. Odactra carries a boxed warning for anaphylaxis and requires co-prescription of an epinephrine auto-injector. It is disease-modifying — same immune-reprogramming mechanism as SCIT. The main difference from injection SCIT is route and visit frequency: daily home dosing versus weekly build-up clinic visits followed by every-2-to-4-week maintenance. Odactra specifically targets HDM (Der p/Der f); SCIT can include HDM alongside other sensitized allergens in the same vial.
Do dust allergy shots help with year-round symptoms?
Yes — dust mite SCIT and the Odactra SLIT tablet treat perennial (year-round) allergic rhinitis because house dust mite exposure is continuous, unlike seasonal pollen. The Cochrane asthma SCIT meta-analysis (Abramson 2010, 88 trials) documented NNT 3 to prevent asthma deterioration in patients receiving allergen-specific SCIT, with HDM comprising a significant portion of the data. HDM SCIT typically produces noticeable benefit within the first 6–12 months of reaching maintenance dose, with progressive improvement over the 3–5 year course. The disease-modifying benefits persist after stopping — though HDM post-treatment durability data is less extensive than the Durham 1999 grass SCIT landmark.
Can dust allergy shots help with asthma as well as nasal symptoms?
Yes — HDM SCIT and SLIT have documented efficacy for both allergic rhinitis and allergic asthma when house dust mite is the driving sensitizer. The Cochrane asthma SCIT meta-analysis (Abramson MJ et al., Cochrane Database Syst Rev 2010;CD001186) across 88 trials found NNT 3 to prevent one episode of asthma deterioration and NNT 5 to prevent increased medication use. Mosbech 2014 JACI documented HDM SLIT tablet significantly reducing inhaled corticosteroid use in asthma patients while maintaining asthma control (n=604). Asthma severity and control status should be evaluated before starting HDM SCIT — unstable or severe asthma (FEV1 < 70% predicted) is a relative contraindication per Cox 2011 PP3. Curex's at-home SCIT program includes allergist review of asthma status and current FEV1 at intake before prescribing the personalized HDM serum.
Related Articles
Types of Allergy Injections: Full Guide | Curex
Types of allergy injections include SCIT (immunotherapy), biologics like Xolair and Dupixent, depot steroids, and epinephrine. Only SCIT modifies the underlying disease.
Read moreDesensitization Allergy: SCIT Guide & Mechanism | Curex
Desensitization for allergy means SCIT — a 3-to-5-year dose-escalation course inducing immune tolerance. Cochrane 51 RCTs: SMD -0.73. Distinct from acute drug desensitization.
Read morePollen Allergy Shot: 3-Way Triage Guide | Curex
Pollen allergy shot triage: depot steroid (discouraged), SLIT tablet, or SCIT. Curex at-home SCIT is category 3: shots weekly at home, $129/month.
Read moreAllergy Shots vs Drops: Evidence-Based Comparison | Curex
Allergy shots (SCIT) vs sublingual drops (SLIT): comparable efficacy per Nelson 2015, but SLIT has zero fatalities vs 1 per 2.5M shots. Full comparison.
Read moreAllergy Shots for Seasonal Allergies | Curex Guide
Yes, allergy shots work for seasonal allergies — Cochrane 51 RCTs found symptom SMD −0.73. Learn who qualifies, what the commitment is, and what 23.9% dropout means.
Read morePollen Allergy Shots: Efficacy & Evidence | Curex Guide
Pollen SCIT has the strongest immunotherapy RCT base: grass 49% symptom reduction (Walker 2001), ragweed NEJM 1996, birch 40% (Bødtger 2002). Full regional map inside.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.